Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Routine Medication
The First People's Hospital of Lianyungang
Generalized Anxiety Disorder
1 trial -
Saturated fat
United Therapeutics Europe Ltd
Cardiovascular Disease
1 trial -
Seasonal malaria chemoprevention
United Therapeutics Europe Ltd
Malaria
1 trial -
Semaglutide, 0.5 mg/mL
United Therapeutics Europe Ltd
Cognitive Change
1 trial -
Sevoflurane
The First People's Hospital of Lianyungang
Anesthesia, General
1 trial -
Sitz-Markers
United Therapeutics Europe Ltd
Return of Bowel Function After Colon Surgery
1 trial -
Solifenacin Succinate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Overactive Bladder
1 trial -
Soy protein
United Therapeutics Europe Ltd
Photoaging
1 trial -
Specific Carbohydrate Diet
NORTHWEST BIOTHERAPEUTICS INC
Clostridium Difficile Infection
1 trial -
Standard Care Arm
United Therapeutics Europe Ltd
Radiation Proctopathy
1 trial -
Stereotactic body radiotherapy (SBRT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
HSCT
1 trial -
Steroid and Proton Pump Inhibitor Therapy
Takeda
Suspected Eosinophilic Esophagitis
1 trial -
Subconjunctival dexamethasone and general anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
Sulfadoxine-pyrimethamine
United Therapeutics Europe Ltd
Anaemia
1 trial -
Sulfentanyl
The First People's Hospital of Lianyungang
Postoperative Nausea and Vomiting
1 trial -
Super Cereal Plus (SC+)
United Therapeutics Europe Ltd
Moderate Acute Malnutrition (MAM)
1 trial -
Supplementary Food
United Therapeutics Europe Ltd
Moderate Acute Malnutrition
1 trial -
Surgery combined with Target-reduction intensity-modulated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Surgery-radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
Synbiotic
United Therapeutics Europe Ltd
Non-Alcoholic Fatty Liver Disease
1 trial -
Synovial Biopsy
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
1 trial -
TCM+ Routine Therapy
The First People's Hospital of Lianyungang
Proteinuria
1 trial -
TRF (Tocotrienol-rich-fraction)
United Therapeutics Europe Ltd
End Stage Renal Disease
1 trial -
Tacrolimus or Cyclosporine A
The First People's Hospital of Lianyungang
Immune Tolerance
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources